But TB treatment has been shadowed by the specter of drug resistance since the dawn of the antibiotic era. Fifteen years ago, an epidemic of multidrug-resistant tuberculosis (MDR-TB) in New York City induced near panic, before a massive infusion of funds into the public health infrastructure turned the tide in the United States, and public interest waned.